Vasundhara Iyengar
Medical Oncology · Clermont, FLNPI 1770548679
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Johnson & Johnson at 30.0% of the total. Reporting peaked in 2021 at $630 and has fallen 56.6% since, to $273 in 2023. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 84 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$512
- Foundation Medicine, Inc.$137
- Pharmacyclics LLC, An Abbvie Company$129
- Amgen$112
- Octapharma USA, Inc.$98
- Novartis$68
- plus $651 from 26 others
What the payments were for
- Food & beverage$1,69499%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 25 | $512 |
| Foundation Medicine, Inc. | 3 | $137 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $129 |
| Amgen | 6 | $112 |
| Octapharma USA, Inc. | 1 | $98 |
| Novartis | 4 | $68 |
| Gilead | 3 | $56 |
| Merck | 3 | $51 |
| Eisai Inc. | 2 | $49 |
| Pfizer | 4 | $47 |
| Bayer | 2 | $43 |
| Genentech USA, Inc. | 3 | $41 |
| Seagen Inc. | 2 | $34 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Sanofi | 1 | $28 |
| GSK | 1 | $25 |
| Aurobindo Pharma USA, Inc. | 1 | $25 |
| Acrotech Biopharma Inc. | 1 | $22 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Taiho Oncology, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $17 |
| AstraZeneca | 1 | $15 |
| AbbVie | 1 | $15 |
| Beigene USA, Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| Sirtex Medical Inc | 1 | $13 |
| Morphosys, US Inc. | 1 | $13 |
| Agios Pharmaceuticals, Inc. | 1 | $12 |
| Secura Bio, Inc. | 1 | $10 |
| Veracyte, Inc. | 1 | $1 |
How this compares
$1,706 in reported general payments places this provider in the 20th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Clermont
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.